F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
Author(s) -
Guoqing Liu,
Jie Sun,
Zekun Li,
Zhenping Chen,
Wenman Wu,
Runhui Wu
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022017871
Subject(s) - serine protease , protease inhibitor (pharmacology) , mutation , factor ix , genetics , serine , biology , medicine , gene , protease , enzyme , biochemistry , virus , phosphorylation , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom